Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Jun 15;21(3):274–280. doi: 10.22074/cellj.2019.6239

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

The Cell Journal (Yakhteh) is an open access journal which means the articles are freely available online for any individual author to download and use the providing address. The journal is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported License which allows the author(s) to hold the copyright without restrictions that is permitting unrestricted use, distribution, and reproduction in any medium provided the original work is properly cited.

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Fig 3 — The effect of MSCs administration on the immunophentype of uDCs. The uterine cells were isolated from uterine of MSC-treated, un-treated group (controlgroup) and normal pregnant (normal-pregnancy) mice at the gd 13.5, stained with monoclonal antibodies against CD45, CD11c and one of the monoclonal antibodies (anti-MHC-II, anti-CD86, anti-CD11b and anti-CD40) then analyzed by flow cytometry. A. The CD11c positive uDCs were selected from the CD45⁺ cells of whole uterine cell population. Then the expression of CD11b, CD86, CD40 and MHC-II on uDCs was evaluated .The red histograms show the isotype controls and B. The graphs indicate that MSCs administration significantly decreased the expression of MHC-II and co-stimulatory molecules (CD86, CD40) on uDCs while CD11b⁺ DCs were not changed following MSC therapy. The differences between the groups were evaluated using a standard parametric test (one-way ANOVA test). The results show the mean ± SD of five independent experiments. **, ***, and ****; p<0.01, p<0.001, and p<0.0001 respectively, MSCs; Mesenchymal stem cells, uDC; Uterine dendritic cells, and NS; Not significant.